Abiopharma

Director Arbuckle Stuart A 🟢 acquired 3.3K shares (1 derivative) of ALNYLAM PHARMACEUTICALS, INC. (ALNY) at $397.83 ($1.3M) Transaction Date: Jan 05, 2026 | Filing ID: 000005

(99% Neutral) MONTE ROSA THERAPEUTICS, INC. (GLUE) Announces Business Combination

📋 Pauwels Eric (Officer) plans to sell 1K shares of PTC THERAPEUTICS, INC. (at $77.48 each, total $105K) Filed: Jan 07, 2026 | ID: 000189

New Form 3 - ALNYLAM PHARMACEUTICALS, INC. Filed: 2026-01-07 AccNo: 0001735276-26-000004 Size: 7 KB

📋 Farrell Michael J. (Officer) plans to sell 5K shares of RESMED INC (at $248.46 each, total $1.2M) Filed: Jan 07, 2026 | ID: 000188

Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases

Director Bitting Kurt 🔴 sold 16.1K shares of Ecovyst Inc. (ECVT) at $9.80 Transaction Date: Jan 05, 2026 | Filing ID: 000012

Feehan Michael 🔴 sold 6.2K shares of Ecovyst Inc. (ECVT) at $9.80 Transaction Date: Jan 05, 2026 | Filing ID: 000011

New Form S-8 POS - CureVac N.V. Filed: 2026-01-07 AccNo: 0001193125-26-006332 Size: 19 KB

New Form S-1 - AETHLON MEDICAL INC Filed: 2026-01-07 AccNo: 0001683168-26-000137 Size: 809 KB

ICON plc (ICLR) Files Form 6-K

(99% Neutral) VENUS CONCEPT INC. (VERO) Announces Business Combination

(80% Positive) bioAffinity Technologies, Inc. (BIAFW) Provides Update on need for laboratory medicine

Jaen Juan C. 🔴 sold 31.8K shares of Arcus Biosciences, Inc. (RCUS) at $23.20 Transaction Date: Jan 05, 2026 | Filing ID: 000002

(99% Neutral) Ecovyst Inc. (ECVT) Reports Q4 2025 Financial Results